GLP-1 Receptor Agonist Use and Survival Among Patients With Type 2 Diabetes and Brain Metastases - PubMed
a day ago
- #diabetes research
- #neuroprotection
- #government websites
- The .gov and .mil domains indicate official U.S. government websites.
- Secure websites use https:// to encrypt and protect transmitted information.
- A cohort study examines GLP-1 RA's effect on survival in type 2 diabetes patients with brain metastases.
- References discuss brain metastasis, diabetes complications, and GLP-1's neuroprotective effects.
- A global platform for real-world data analytics in research is highlighted.